Chang Yi Wang

From Wikipedia, the free encyclopedia

Chang Yi Wang (王長怡)
ChangYiWang.jpg
Born (1951-12-19) December 19, 1951 (age 70)
Alma mater
Known for
  • Synthetic peptide based immunological applications in diagnostics, vaccines and immunotherapeutics.
  • Protein drugs including innovative monoclonal antibodies and long acting protein drugs.
Spouse(s)Nean Hu
ChildrenMei Mei Hu
Scientific career
Institutions
Doctoral advisorHenry Kunkel
Other academic advisors

Chang Yi Wang (traditional Chinese: 王長怡; simplified Chinese: 王长怡) is the founder of United Biomedical, Inc. (UBI), headquartered in Hauppauge, New York, and its group of companies in Asia.

Wang was born in Taiwan in 1951.[1] Her father was a member of the National Assembly. She majored in organic chemistry when she was undergraduate and then went to Rockefeller University for doctor's degree. In 1985, Wang founded United Biomedical, Inc in New York whose main business is medicine and vaccine development.[2] She founded United Biomedical, Inc Asia in Taiwan in 1998.[1]

Wang is the author of more than 120 peer-reviewed scientific publications and she is the inventor of more than 80 patents to date.[3] In 2007, the New York Intellectual Property Law Association (NYIPLA) presented Wang with the Inventor of the Year Award.[4] In 2018, the Brain Mapping Foundation presented Wang with the Pioneer in Technology Award.[5]

Early life and education[]

Wang graduated with honor from National Taiwan University in 1973, majoring in chemistry. She received a Ph.D. degree from Rockefeller University with dual specialization in Biochemistry and Immunology in 1979 and then joined the Memorial Sloan Kettering Cancer Center as the youngest faculty member, principal investigator and head of the molecular immunology laboratory.[6]

Career in immunology and entrepreneurship in the biomedical industry[]

Chang Yi Wang also founded UBI Asia subsidiary companies in Asia : United Biopharma in 2013[7] and UBI Pharma in 2014[8] respectively.

In 2009, Bill and Melinda Gates Foundation Awarded Grand Challenges Exploration Grants to Chang Yi Wang, for the Synthetic Peptides to Inhibit HIV Entry program.[9]

Professional and honorary affiliations[]

References[]

  1. ^ a b "王長怡×王瑞瑜 突破台灣生技盲點|天下雜誌". 天下雜誌 (in Chinese). Retrieved October 6, 2019.
  2. ^ "人物側寫-8萬美元起家 王長怡 締造生技業奇蹟 - 財經要聞". 中時電子報 (in Chinese). Retrieved October 6, 2019.
  3. ^ "Publication". www.unitedbiomedical.com. Publication. Retrieved October 7, 2019.
  4. ^ "United Biomedical, Inc. CEO Dr. Chang Yi Wang named Inventor of the Year 2007 by New York Intellectual Property Law Association". NewsRx. June 17, 2007. Archived from the original on September 28, 2011. Retrieved August 5, 2011.
  5. ^ "Pioneer in Technology Award". www.worldbrainmapping.org. Retrieved October 7, 2019.
  6. ^ "A vaccine for Alzheimer's is on the verge of becoming a reality". www.wired.co.uk. Retrieved October 11, 2019.
  7. ^ "About United BioPharma". www.unitedbiopharma.com. Retrieved October 11, 2019.
  8. ^ "UBI Pharma Company Overview". www.ubi-pharma.com. Retrieved October 11, 2019.
  9. ^ "Global Grand Challenges". gcgh.grandchallenges.org. Retrieved October 11, 2019.

External links[]

Retrieved from ""